Citigroup’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-54,839
| Closed | -$4.13M | – | 5838 |
|
|
2022
Q2 | $4.13M | Buy |
54,839
+20,567
| +60% | +$1.55M | ﹤0.01% | 1210 |
|
|
2022
Q1 | $920K | Sell |
34,272
-79,131
| -70% | -$2.12M | ﹤0.01% | 2425 |
|
|
2021
Q4 | $5.41M | Buy |
113,403
+78,514
| +225% | +$3.74M | ﹤0.01% | 1236 |
|
|
2021
Q3 | $2.32M | Sell |
34,889
-25,972
| -43% | -$1.72M | ﹤0.01% | 1805 |
|
|
2021
Q2 | $4.75M | Buy |
60,861
+18,942
| +45% | +$1.48M | ﹤0.01% | 1454 |
|
|
2021
Q1 | $3.97M | Buy |
41,919
+15,390
| +58% | +$1.46M | ﹤0.01% | 1488 |
|
|
2020
Q4 | $3.23M | Buy |
26,529
+6,783
| +34% | +$826K | ﹤0.01% | 1446 |
|
|
2020
Q3 | $1.73M | Sell |
19,746
-14,751
| -43% | -$1.29M | ﹤0.01% | 1592 |
|
|
2020
Q2 | $2.23M | Buy |
34,497
+10,784
| +45% | +$696K | ﹤0.01% | 1558 |
|
|
2020
Q1 | $1.06M | Sell |
23,713
-3,420
| -13% | -$153K | ﹤0.01% | 1775 |
|
|
2019
Q4 | $1.69M | Buy |
27,133
+12,998
| +92% | +$810K | ﹤0.01% | 1817 |
|
|
2019
Q3 | $531K | Buy |
14,135
+12,283
| +663% | +$461K | ﹤0.01% | 2542 |
|
|
2019
Q2 | $75K | Buy |
+1,852
| New | +$75K | ﹤0.01% | 3822 |
|